ID   IGF1R_RAT               Reviewed;        1370 AA.
AC   P24062;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   02-OCT-2024, entry version 209.
DE   RecName: Full=Insulin-like growth factor 1 receptor;
DE            EC=2.7.10.1;
DE   AltName: Full=Insulin-like growth factor I receptor;
DE            Short=IGF-I receptor;
DE   AltName: CD_antigen=CD221;
DE   Contains:
DE     RecName: Full=Insulin-like growth factor 1 receptor alpha chain;
DE   Contains:
DE     RecName: Full=Insulin-like growth factor 1 receptor beta chain;
DE   Flags: Precursor;
GN   Name=Igf1r;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7758167; DOI=10.1161/01.res.76.6.963;
RA   Du J., Delafontaine P.;
RT   "Inhibition of vascular smooth muscle cell growth through antisense
RT   transcription of a rat insulin-like growth factor I receptor cDNA.";
RL   Circ. Res. 76:963-972(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-364.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2477843; DOI=10.1073/pnas.86.19.7451;
RA   Werner H., Woloschak M., Adamo M., Shen-Orr Z., Roberts C.T. Jr.,
RA   Leroith D.;
RT   "Developmental regulation of the rat insulin-like growth factor I receptor
RT   gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:7451-7455(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 913-1017.
RX   PubMed=1530648; DOI=10.1016/0006-291x(92)91287-z;
RA   Kurachi H., Jobo K., Ohta M., Kawasaki T., Itoh N.;
RT   "A new member of the insulin receptor family, insulin receptor-related
RT   receptor, is expressed preferentially in the kidney.";
RL   Biochem. Biophys. Res. Commun. 187:934-939(1992).
RN   [4]
RP   FUNCTION, AND FORMATION OF A HYBRID RECEPTOR WITH INSR.
RX   PubMed=16803852; DOI=10.1152/ajpendo.00565.2005;
RA   Johansson G.S., Arnqvist H.J.;
RT   "Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid
RT   insulin/IGF-I receptors in vascular smooth muscle cells.";
RL   Am. J. Physiol. 291:E1124-E1130(2006).
CC   -!- FUNCTION: Receptor tyrosine kinase which mediates actions of insulin-
CC       like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and
CC       insulin (INS) with a lower affinity. The activated IGF1R is involved in
CC       cell growth and survival control. IGF1R is crucial for tumor
CC       transformation and survival of malignant cell. Ligand binding activates
CC       the receptor kinase, leading to receptor autophosphorylation, and
CC       tyrosines phosphorylation of multiple substrates, that function as
CC       signaling adapter proteins including, the insulin-receptor substrates
CC       (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins
CC       lead to the activation of two main signaling pathways: the PI3K-AKT/PKB
CC       pathway and the Ras-MAPK pathway. The result of activating the MAPK
CC       pathway is increased cellular proliferation, whereas activating the
CC       PI3K pathway inhibits apoptosis and stimulates protein synthesis.
CC       Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K
CC       (PIK3R1), leading to activation of several downstream substrates,
CC       including protein AKT/PKB. AKT phosphorylation, in turn, enhances
CC       protein synthesis through mTOR activation and triggers the
CC       antiapoptotic effects of IGFIR through phosphorylation and inactivation
CC       of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS
CC       by phosphorylated IRS1 or Shc leads to recruitment of Ras and
CC       activation of the ras-MAPK pathway. In addition to these two main
CC       signaling pathways IGF1R signals also through the Janus kinase/signal
CC       transducer and activator of transcription pathway (JAK/STAT).
CC       Phosphorylation of JAK proteins can lead to phosphorylation/activation
CC       of signal transducers and activators of transcription (STAT) proteins.
CC       In particular activation of STAT3, may be essential for the
CC       transforming activity of IGF1R. The JAK/STAT pathway activates gene
CC       transcription and may be responsible for the transforming activity. JNK
CC       kinases can also be activated by the IGF1R. IGF1 exerts inhibiting
CC       activities on JNK activation via phosphorylation and inhibition of
CC       MAP3K5/ASK1, which is able to directly associate with the IGF1R (By
CC       similarity). When present in a hybrid receptor with INSR, binds IGF1
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:16803852}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Activated by autophosphorylation at Tyr-1162, Tyr-
CC       1166 and Tyr-1167 on the kinase activation loop; phosphorylation at all
CC       three tyrosine residues is required for optimal kinase activity.
CC       Inhibited by MSC1609119A-1, BMS-754807, PQIP, benzimidazole pyridinone,
CC       isoquinolinedione, bis-azaindole, 3-cyanoquinoline, 2,4-bis-arylamino-
CC       1,3-pyrimidine, pyrrolopyrimidine, pyrrole-5-carboxaldehyde,
CC       picropodophyllin (PPP), tyrphostin derivatives. While most inhibitors
CC       bind to the ATP binding pocket, MSC1609119A-1 functions as allosteric
CC       inhibitor and binds close to the DFG motif and the activation loop (By
CC       similarity). Dephosphorylated by PTPN1 (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Tetramer of 2 alpha and 2 beta chains linked by disulfide
CC       bonds. The alpha chains contribute to the formation of the ligand-
CC       binding domain, while the beta chain carries the kinase domain.
CC       Interacts with PIK3R1 and with the PTB/PID domains of IRS1 and SHC1 in
CC       vitro when autophosphorylated on tyrosine residues. Forms a hybrid
CC       receptor with INSR, the hybrid is a tetramer consisting of 1 alpha
CC       chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of
CC       IGF1R. Interacts with ARRB1 and ARRB2. Interacts with GRB10. Interacts
CC       with RACK1 (By similarity). Interacts with SOCS1, SOCS2 and SOCS3 (By
CC       similarity). Interacts with 14-3-3 proteins (By similarity). Interacts
CC       with NMD2 (By similarity). Interacts with MAP3K5 (By similarity).
CC       Interacts with STAT3. Found in a ternary complex with IGF1 and
CC       ITGAV:ITGB3 or ITGA6:ITGB4 (By similarity). Interacts (nascent
CC       precursor form) with ZFAND2B (By similarity).
CC       {ECO:0000250|UniProtKB:P08069}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on tyrosine residues in response to ligand
CC       binding. Autophosphorylation occurs in trans, i.e. one subunit of the
CC       dimeric receptor phosphorylates tyrosine residues on the other subunit.
CC       Autophosphorylation occurs in a sequential manner; Tyr-1166 is
CC       predominantly phosphorylated first, followed by phosphorylation of Tyr-
CC       1162 and Tyr-1167. While every single phosphorylation increases kinase
CC       activity, all three tyrosine residues in the kinase activation loop
CC       (Tyr-1162, Tyr-1166 and Tyr-1167) have to be phosphorylated for optimal
CC       activity. Can be autophosphorylated at additional tyrosine residues (in
CC       vitro). Autophosphorylated is followed by phosphorylation of
CC       juxtamembrane tyrosines and C-terminal serines. Phosphorylation of Tyr-
CC       981 is required for IRS1- and SHC1-binding. Phosphorylation of Ser-1279
CC       by GSK-3beta restrains kinase activity and promotes cell surface
CC       expression, it requires a priming phosphorylation at Ser-1283 (By
CC       similarity). Dephosphorylated by PTPN1. {ECO:0000250}.
CC   -!- PTM: Polyubiquitinated at Lys-1169 and Lys-1172 through both 'Lys-48'
CC       and 'Lys-29' linkages, promoting receptor endocytosis and subsequent
CC       degradation by the proteasome. Ubiquitination is facilitated by pre-
CC       existing phosphorylation (By similarity). {ECO:0000250}.
CC   -!- PTM: Sumoylated with SUMO1. {ECO:0000250}.
CC   -!- PTM: Controlled by regulated intramembrane proteolysis (RIP). Undergoes
CC       metalloprotease-dependent constitutive ectodomain shedding to produce a
CC       membrane-anchored 52 kDa C-Terminal fragment which is further processed
CC       by presenilin gamma-secretase to yield an intracellular 50 kDa fragment
CC       (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29232; AAA41392.1; -; mRNA.
DR   EMBL; M27293; AAA41384.1; -; mRNA.
DR   RefSeq; NP_434694.1; NM_052807.2.
DR   AlphaFoldDB; P24062; -.
DR   SMR; P24062; -.
DR   BioGRID; 247747; 2.
DR   STRING; 10116.ENSRNOP00000019267; -.
DR   BindingDB; P24062; -.
DR   ChEMBL; CHEMBL1075098; -.
DR   GlyCosmos; P24062; 16 sites, No reported glycans.
DR   GlyGen; P24062; 16 sites.
DR   iPTMnet; P24062; -.
DR   PhosphoSitePlus; P24062; -.
DR   PaxDb; 10116-ENSRNOP00000019267; -.
DR   Ensembl; ENSRNOT00000019267.7; ENSRNOP00000019267.7; ENSRNOG00000014187.7.
DR   GeneID; 25718; -.
DR   KEGG; rno:25718; -.
DR   UCSC; RGD:2869; rat.
DR   AGR; RGD:2869; -.
DR   CTD; 3480; -.
DR   RGD; 2869; Igf1r.
DR   eggNOG; KOG4258; Eukaryota.
DR   GeneTree; ENSGT00940000156682; -.
DR   HOGENOM; CLU_000288_166_0_1; -.
DR   InParanoid; P24062; -.
DR   OMA; HRCWHHR; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; P24062; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-2404192; Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R).
DR   Reactome; R-RNO-2428928; IRS-related events triggered by IGF1R.
DR   Reactome; R-RNO-2428933; SHC-related events triggered by IGF1R.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   PRO; PR:P24062; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   GO; GO:0035867; C:alphav-beta3 integrin-IGF-1-IGF1R complex; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005899; C:insulin receptor complex; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:1902911; C:protein kinase complex; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0030315; C:T-tubule; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043559; F:insulin binding; ISO:RGD.
DR   GO; GO:0005009; F:insulin receptor activity; IBA:GO_Central.
DR   GO; GO:0005158; F:insulin receptor binding; ISO:RGD.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IPI:RGD.
DR   GO; GO:0005520; F:insulin-like growth factor binding; ISS:UniProtKB.
DR   GO; GO:0031994; F:insulin-like growth factor I binding; ISO:RGD.
DR   GO; GO:0005010; F:insulin-like growth factor receptor activity; IDA:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; ISS:UniProtKB.
DR   GO; GO:0140318; F:protein transporter activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0005198; F:structural molecule activity; ISS:UniProtKB.
DR   GO; GO:0030325; P:adrenal gland development; ISO:RGD.
DR   GO; GO:0097242; P:amyloid-beta clearance; ISO:RGD.
DR   GO; GO:0009887; P:animal organ morphogenesis; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; IMP:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0003230; P:cardiac atrium development; IEP:RGD.
DR   GO; GO:1904045; P:cellular response to aldosterone; IEP:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:1990314; P:cellular response to insulin-like growth factor stimulus; IPI:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0071393; P:cellular response to progesterone stimulus; IEP:RGD.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IPI:RGD.
DR   GO; GO:0034224; P:cellular response to zinc ion starvation; IEP:RGD.
DR   GO; GO:0090398; P:cellular senescence; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IMP:RGD.
DR   GO; GO:0097062; P:dendritic spine maintenance; IGI:ARUK-UCL.
DR   GO; GO:0008544; P:epidermis development; ISO:RGD.
DR   GO; GO:0030010; P:establishment of cell polarity; IMP:RGD.
DR   GO; GO:0044849; P:estrous cycle; IMP:RGD.
DR   GO; GO:0031017; P:exocrine pancreas development; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0006955; P:immune response; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IMP:ARUK-UCL.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030238; P:male sex determination; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0140014; P:mitotic nuclear division; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:1904193; P:negative regulation of cholangiocyte apoptotic process; IMP:RGD.
DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; IMP:RGD.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0010656; P:negative regulation of muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; IDA:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0048680; P:positive regulation of axon regeneration; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:RGD.
DR   GO; GO:0048639; P:positive regulation of developmental growth; ISO:RGD.
DR   GO; GO:0051054; P:positive regulation of DNA metabolic process; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0051446; P:positive regulation of meiotic cell cycle; ISO:RGD.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; ISO:RGD.
DR   GO; GO:0033690; P:positive regulation of osteoblast proliferation; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:RGD.
DR   GO; GO:0043243; P:positive regulation of protein-containing complex disassembly; IGI:ARUK-UCL.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0090031; P:positive regulation of steroid hormone biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0099170; P:postsynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; ISO:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0046328; P:regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:0043279; P:response to alkaloid; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IDA:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:1902065; P:response to L-glutamate; IDA:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0033197; P:response to vitamin E; IEP:RGD.
DR   GO; GO:0045056; P:transcytosis; ISO:RGD.
DR   CDD; cd00063; FN3; 3.
DR   CDD; cd00064; FU; 1.
DR   CDD; cd05032; PTKc_InsR_like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   Gene3D; 3.80.20.20; Receptor L-domain; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016246; Tyr_kinase_insulin-like_rcpt.
DR   InterPro; IPR002011; Tyr_kinase_rcpt_2_CS.
DR   PANTHER; PTHR24416:SF106; INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000620; Insulin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00261; FU; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 3.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF52058; L domain-like; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell membrane; Cleavage on pair of basic residues;
KW   Disulfide bond; Glycoprotein; Isopeptide bond; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..737
FT                   /note="Insulin-like growth factor 1 receptor alpha chain"
FT                   /id="PRO_0000016685"
FT   CHAIN           742..1370
FT                   /note="Insulin-like growth factor 1 receptor beta chain"
FT                   /id="PRO_0000016686"
FT   TOPO_DOM        742..936
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        937..960
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        961..1370
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          490..610
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          611..709
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          835..928
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1000..1275
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1304..1370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           978..981
FT                   /note="IRS1- and SHC1-binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        1136
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         1006..1014
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         1034
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         981
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P08069"
FT   MOD_RES         1162
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P08069"
FT   MOD_RES         1166
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P08069"
FT   MOD_RES         1167
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P08069"
FT   MOD_RES         1279
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q60751"
FT   MOD_RES         1283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60751"
FT   CARBOHYD        51
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        102
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        245
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        314
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        418
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        439
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        535
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        608
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        623
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        641
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        748
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        757
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        765
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        901
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        914
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..52
FT                   /evidence="ECO:0000250"
FT   DISULFID        150..178
FT                   /evidence="ECO:0000250"
FT   DISULFID        182..205
FT                   /evidence="ECO:0000250"
FT   DISULFID        192..211
FT                   /evidence="ECO:0000250"
FT   DISULFID        215..224
FT                   /evidence="ECO:0000250"
FT   DISULFID        219..230
FT                   /evidence="ECO:0000250"
FT   DISULFID        231..239
FT                   /evidence="ECO:0000250"
FT   DISULFID        235..248
FT                   /evidence="ECO:0000250"
FT   DISULFID        251..260
FT                   /evidence="ECO:0000250"
FT   DISULFID        264..276
FT                   /evidence="ECO:0000250"
FT   DISULFID        282..303
FT                   /evidence="ECO:0000250"
FT   DISULFID        307..321
FT                   /evidence="ECO:0000250"
FT   DISULFID        324..328
FT                   /evidence="ECO:0000250"
FT   DISULFID        332..354
FT                   /evidence="ECO:0000250"
FT   DISULFID        456..489
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        1169
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P08069"
FT   CROSSLNK        1172
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P08069"
FT   CONFLICT        985..986
FT                   /note="AD -> PY (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1370 AA;  155396 MW;  A5946897A41CB145 CRC64;
     MKSGSGGGSP TSLWGLVFLS AALSLWPTSG EICGPGIDIR NDYQQLKRLE NCTVIEGFLH
     ILLISKAEDY RSYRFPKLTV ITEYLLLFRV AGLESLGDLF PNLTVIRGWK LFYNYALVIF
     EMTNLKDIGL YNLRNITRGA IRIEKNADLC YLSTIDWSLI LDAVSNNYIV GNKPPKECGD
     LCPGTLEEKP MCEKTTINNE YNYRCWTTNR CQKMCPSVCG KRACTENNEC CHPECLGSCH
     TPDDNTTCVA CRHYYYKGVC VPACPPGTYR FEGWRCVDRD FCANIPNAES SDSDGFVIHD
     GECMQECPSG FIRNSTQSMY CIPCEGPCPK VCGDEEKKTK TIDSVTSAQM LQGCTILKGN
     LLINIRRGNN IASELENFMG LIEVVTGYVK IRHSHALVSL SFLKNLRLIL GEEQLEGNYS
     FYVLDNQNLQ QLWDWNHRNL TVRSGKMYFA FNPKLCVSEI YRMEEVTGTK GRQSKGDINT
     RNNGERASCE SDVLRFTSTT TWKNRIIITW HRYRPPDYRD LISFTVYYKE APFKNVTEYD
     GQDACGSNSW NMVDVDLPPN KEGEPGILLH GLKPWTQYAV YVKAVTLTMV ENDHIRGAKS
     EILYIRTNAS VPSIPLDVLS ASNSSSQLIV KWNPPTLPNG NLSYYIVRWQ RQPQDGYLFR
     HNYCSKDKIP IRKYADGTID VEEVTENPKT EVCGGDKGPC CACPKTEAEK QAEKEEAEYR
     KVFENFLHNS IFVPRPERRR RDVLQVANTT MSSRSRNTTV ADTYNITDPE EFETEYPFFE
     SRVDNKERTV ISNLRPFTLY RIDIHSCNHE AEKLGCSASN FVFARTMPAE GADDIPGPVT
     WEPRPENSIF LKWPEPENPN GLILMYEIKY GSQVEDQREC VSRQEYRKYG GAKLNRLNPG
     NYTARIQATS LSGNGSWTDP VFFYVPAKTT YENFMHLIIA LPVAILLIVG GLVIMLYVFH
     RKRNNSRLGN GVLYASVNPE YFSAADVYVP DEWEVAREKI TMNRELGQGS FGMVYEGVAK
     GVVKDEPETR VAIKTVNEAA SMRERIEFLN EASVMKEFNC HHVVRLLGVV SQGQPTLVIM
     ELMTRGDLKS YLRSLRPEVE NNLVLIPPSL SKMIQMAGEI ADGMAYLNAN KFVHRDLAAR
     NCMVAEDFTV KIGDFGMTRD IYETDYYRKG GKGLLPVRWM SPESLKDGVF TTHSDVWSFG
     VVLWEIATLA EQPYQGLSNE QVLRFVMEGG LLDKPDNCPD MLFELMRMCW QYNPKMRPSF
     LEIIGSIKDE MEPSFQEVSF YYSEENKPPE PEELEMELEL EPENMESVPL DPSASSASLP
     LPERHSGHKA ENGPGVLVLR ASFDERQPYA HMNGGRANER ALPLPQSSTC
//
